Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine versus aripiprazole in psychotic disorders
IRCT20200430047250N1Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Schizophrenia Spectrum Disorders (SSD) comparing Olanzapine arm with Aripiprazole arm (2 arms). Primary endpoints: Body mass index and Efficacy of olanzapine and aripiprazole. Started Jul 2020; status: completed.
02
Drugs
olanzapinearipiprazole
03
Conditions
Schizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on IRCT20200430047250N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200430047250N1.